dabigatran has been researched along with Conjunctival Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bender, J; Bryant, G; Koenigsfeld, C; Lehman, N; Logemann, C; Sayler, M | 1 |
| Huff, CM; Nguyen, TM; Phelan, MP; Rychwalski, PJ; Werdich, XQ | 1 |
2 other study(ies) available for dabigatran and Conjunctival Diseases
| Article | Year |
|---|---|
Left subconjunctival hemorrhage · renal dysfunction · international normalized ratio of 4.5 · Dx?
Topics: Aged; Antithrombins; Atrial Fibrillation; Conjunctival Diseases; Dabigatran; Drug Interactions; Drug Substitution; Eye Hemorrhage; Female; Humans; Immunosuppressive Agents; International Normalized Ratio; Liver Transplantation; Renal Insufficiency; Tacrolimus; Treatment Outcome | 2015 |
Subconjunctival hemorrhage in a patient on dabigatran (Pradaxa).
Topics: Acute Disease; Aged; Antithrombins; Benzimidazoles; Conjunctival Diseases; Dabigatran; Eye Hemorrhage; Humans; Male; Pyridines | 2013 |